Dr. Sandria Vernon, MD/MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10085 William Bernart Circle, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
Mr. Linwood Thomas Joyner Ii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10085 William F. Bernart Circle, Nassawadox, VA 23413 Phone: 757-442-6600 |
Angelica Perry, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9524 Hospital Avenue, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
John Wilton Snyder Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9524 Hospital Avenue, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
News Archive
Endo Pharmaceuticals today announced the successful completion of the tender offer by its indirect wholly owned subsidiary, West Acquisition Corp., for all of the outstanding shares of common stock of Penwest Pharmaceuticals Co.
"Hospitals that disproportionately care for poor patients are less likely than other hospitals to have adopted health information technology," according to an October study published in Health Affairs, American Medical News reports. The economic stimulus legislation in February directed $19 billion in federal investments to help all types of hospitals adopt electronic records, but some researchers are concerned the money may not close that divide.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today that the Company has filed a Certificate of Change with the Secretary of State of Nevada, which implements a share consolidation of the Company's authorized and outstanding common stock on a ten (old) for one (new) basis.
Essentialis, Inc. announced today that the United States Patent & Trademark Office (USPTO) has issued U.S. Patent No. 7,799,777 entitled Salts of potassium ATP channel openers and uses thereof. The patent claims a novel composition of a polymorph of diazoxide choline, the active ingredient in the Essentialis lead product, DCCR. Essentialis has successfully completed phase 2b clinical trials with DCCR, showing a highly significant triglyceride reduction in dyslipidemic patients.
A new study of the records of millions of nursing home residents affirms the value of influenza vaccination among the elderly. The Brown University analysis found that between 2000 and 2009, the better matched the vaccine was for the influenza strain going around, the fewer nursing home residents died or were hospitalized.
› Verified 9 days ago